Urocortin II, human CAS NO.398001-88-2

Urocortin II, human CAS NO.398001-88-2

Urocortin II, human CAS NO.398001-88-2

Urocortin II, human CAS NO.398001-88-2

Urocortin II, human CAS NO.398001-88-2

Urocortin II, human is a 38-amino acid C-terminal amidated neuropeptide that functions as a selective agonist for corticotropin-releasing hormone receptor 2 (CRHR2), supplied as a lyophilized powder with ≥95% HPLC purity and low endotoxin levels. This research-grade peptide is derived from the human sequence and is designed for studies of stress response, anxiety, appetite regulation, and cardiovascular function in human-relevant in vitrosystems. It serves as a critical tool for investigating CRHR2-mediated signaling pathways and the physiological roles of the urocortin system in energy homeostasis and stress adaptation, providing researchers with a reliable reagent for dissecting species-specific effects.



TECHNICAL SPECIFICATIONS


Item
Specification
Product Name
Urocortin II, human
CAS NO.
398001-88-2
Appearance
White to off-white lyophilized powder
Molecular Formula
 C194H338N63O54S1
Molecular Weight
 4449.31g/mol 
Purity (RP-HPLC)
≥ 95.0%
Solubility

Soluble in water, phosphate‑buffered saline (PBS), or dilute acetic acid (e.g., 0.1% v/v). It is recommended to first dissolve in a small volume of 0.1% acetic acid or sterile water to prepare a 0.1–1.0 mg/mL stock solution.

Endotoxin< 1.0 EU/mg
Biological Activity
Human urocortin II is a selective agonist for the corticotropin‑releasing hormone receptor 2 (CRHR2). It mediates stress‑related responses, including anxiety‑like behaviors, appetite suppression, and cardiovascular effects. Bioactivity can be validated in CRHR2‑expressing cell‑based assays (e.g., cAMP accumulation).
Storage Conditions
Lyophilized powder: Store desiccated at –20 °C or below, protected from light, for long‑term stability.
Reconstituted solution: Aliquot and store at ≤ –20 °C; avoid repeated freeze‑thaw cycles. For extended stability, store at –80 °C.
Stock Location
Stock in USA
MOQ
1g


1.MECHANISM OF ACTION

Urocortin II, human selectively binds to CRHR2 with high affinity, activating Gs-coupled signaling pathways that stimulate adenylate cyclase and elevate intracellular cAMP levels. This activation modulates downstream effectors involved in stress response, including regulation of hypothalamic-pituitary-adrenal axis activity, neurotransmitter release, and cardiovascular function through vasodilation and positive inotropy. The peptide exhibits minimal cross-reactivity with CRHR1, making it an ideal tool for studying CRHR2-specific physiological responses such as anxiety-like behaviors, appetite suppression, and stress-induced cardiovascular changes in human cell-based models and cross-species comparisons.


2.PRODUCT INDICATIONS

This peptide is indicated for research applications focused on stress physiology, anxiety disorders, appetite regulation, and cardiovascular function in human-relevant in vitrosystems. It is utilized in in vitroassays with CRHR2-expressing cells to study cAMP accumulation, receptor binding kinetics, and signal transduction pathways. The product also serves as a reference standard for autoradiography, immunohistochemistry, and functional studies to localize CRHR2 expression and activity in human tissues and cell lines, contributing to the understanding of stress-related and metabolic disorders.


3.CLINICAL EFFICACY OF PRODUCT

Urocortin II, human has no clinical efficacy or safety profile, as it is strictly a research reagent for preclinical investigations. The peptide has not undergone clinical trials, regulatory evaluation, or safety assessment for diagnostic or therapeutic use in humans. While preclinical studies demonstrate its potent effects on stress response and cardiovascular function in human cell-based models, these findings remain exploratory and have not been translated into validated clinical interventions. Any potential therapeutic applications would require the development of distinct agents with comprehensive pharmacokinetic and safety evaluations.


4.DELIVERY & SHIPPING

We specialize in global logistics for various cosmetic peptides. Your order will be handled with the utmost care, ensuring safe, reliable, and intact delivery.
Professional and Secure Packaging
Each bottle of peptide is protected with a special packaging solution to ensure stability and integrity during transportation.
We can also customize packaging according to customer needs.
Shipping Methods 
Main Method: International Air Freight

We primarily use DHL, FedEx, UPS, and TNT because of their global reliability, speed, and advanced tracking systems. Air freight ensures the fastest transit time and minimizes the impact of environmental factors on the product.

Premium API Oxandrolone Ucinky Manufacturing
May 25, 26
Premium API Oxandrolone Ucinky Manufacturing
Premium API Oxandrolone Ucinky Manufacturing Leading global supplier of high-purity chemical raw materials for pharmaceutical grade Oxandrolone Ucinky, combining precision engineering with industrial scale. 5000 kg Annual Output 120 Countries Served 5 Days Sample Lead Time 99.7 On-Time Delivery Industrial Precision Pure Chemical Synthesis Engineering the future of pharmaceutical intermediates with unmatched stability. Our facility stands as a global leader in the oxandrolone ucinky sector, utilizing CRYOGENIC CRYSTALLIZATION and advanced chromatography to ensure an assay purity exceeding 99.8. We integrate a fully automated closed-loop system that eliminates human error and contamination.
Clinical Benefits and Applications of Oxandrolone Therapy
May 22, 26
Clinical Benefits and Applications of Oxandrolone Therapy
Oxandrolone therapy represents a sophisticated intersection of endocrine science and regenerative medicine, primarily utilized to address muscle wasting and metabolic dysfunction. In the global pharmaceutical landscape, this specific approach to androgen therapy is valued for its unique ability to promote protein synthesis while exhibiting a lower androgenic profile compared to traditional steroids, making it a critical tool for patients recovering from severe trauma or chronic illness. From a clinical perspective, understanding the nuances of oxandrolone therapy is essential for optimizing patient outcomes in weight gain and tissue repair.
Clinical Benefits and Production of Oxandrolone Steroid
May 20, 26
Clinical Benefits and Production of Oxandrolone Steroid
The global pharmaceutical landscape has seen a significant rise in the demand for highly specialized anabolic agents, among which the oxandrolone steroid stands out due to its unique chemical profile and therapeutic versatility. As a modified version of dihydrotestosterone, this compound provides a potent means of addressing muscle wasting and metabolic deficits, making it a critical asset in both clinical rehabilitation and advanced physiological research. Understanding the nuances of this synthetic compound is essential for healthcare providers and researchers alike, as it balances efficacy with a relatively lower androgenic profile compared to other steroids.

If you are interested in our products, you can choose to leave your information here, and we will be in touch with you shortly.